Cargando…
MYC overexpression leads to increased chromatin interactions at super-enhancers and MYC binding sites
The MYC oncogene encodes for the MYC protein and is frequently dysregulated across multiple cancer cell types, making it an attractive target for cancer therapy. MYC overexpression leads to MYC binding at active enhancers, resulting in a global transcriptional amplification of active genes. Because...
Autores principales: | See, Yi Xiang, Chen, Kaijing, Fullwood, Melissa J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997345/ https://www.ncbi.nlm.nih.gov/pubmed/35115371 http://dx.doi.org/10.1101/gr.276313.121 |
Ejemplares similares
-
Promiscuous Rearrangements of the MYC Locus Hijack Enhancers and Super-Enhancers to Dysregulate MYC Expression in Multiple Myeloma
por: Affer, Maurizio, et al.
Publicado: (2014) -
Deep learning for MYC binding site recognition
por: Fioresi, R., et al.
Publicado: (2022) -
Androgen receptor and MYC equilibration centralizes on developmental super-enhancer
por: Guo, Haiyang, et al.
Publicado: (2021) -
TXNIP loss expands Myc-dependent transcriptional programs by increasing Myc genomic binding
por: Lim, Tian-Yeh, et al.
Publicado: (2023) -
A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)